EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, VALN: Valneva Se ADR

13 Nov 25 15:22
LAST:

9.220

CHANGE:
 0.03		OPEN:
9.350		HIGH:
9.500		ASK:
0.000		VOLUME:
13.8K
CHG(%):
0.33		PREV:
9.190		LOW:
9.020		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
13 Nov 259.3509.5009.0209.22013.8K
12 Nov 259.0529.2358.9909.1906.0K
11 Nov 258.8309.0308.8208.8908.5K
10 Nov 258.7009.0508.6708.88526.4K
07 Nov 258.6208.9408.5008.720113.6K
06 Nov 258.8308.9008.7408.90011.2K
05 Nov 259.0009.0658.8829.0009.9K
04 Nov 259.2109.2759.0309.0809.8K
03 Nov 259.1709.1809.0109.05020.9K
31 Oct 259.3809.5709.2629.2709.0K

COMPANY PROFILE

Name:Valneva Se ADR
About:Valneva SE, a specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs. It offers IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; DUKORAL, an oral vaccine for the prevention of diarrhea caused by Vibrio cholera or heat-labile toxin producing enterotoxigenic Escherichia coli bacterium; and IXCHIQ/ VLA1553, a single-dose, live-attenuated vaccine for the prevention of disease caused by chikungunya virus. The company also develops VLA15, a vaccine candidate against Borrelia, the bacterium that causes Lyme disease; S4V2, a tetravalent bioconjugate vaccine candidate against shigellosis, a diarrheal infection caused by Shigella bacteria; VLA1601, a vaccine candidate targeting the Zika virus, a mosquito-borne viral disease; VLA1554, a vaccine candidate targeting human metapneumovirus; VLA84, a vaccine candidate targeting the prevention of primary symptomatic clostridium difficile infection; and VLA2112, a vaccine candidate to treat patients with epstein-barr virus. It sells its products in the United States, Canada, Germany, Austria, Nordics, the United Kingdom, France, rest of Europe, and internationally. The company was founded in 1998 and is based in Saint-Herblain, France.
Sector:Healthcare
Industry:Biotechnology
Address:6 rue Alain Bombard, Saint-Herblain, France, 44800
Website:https://valneva.com
ISIN:US92025Y1038
FIGI:BBG00ZZPBH08

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:72.74 
Forward P/E:-16.55 
PEG Ratio:-16.55 
Price to Sales:4.05 
Price to Book:8.28 
Profit Margin:-0.34 
Operating Margin:-0.22 
Return on Assets:-0.07 
Return on Equity:-0.38 
EPS Ratio:-1.08 
Revenue:226.46M 
EBITDA:40.39M 
Shares:85.87M 
Market Cap:791.68M 

TECHNICAL INDICATORS

MA5:8.982.7%
MA10:9.022.2%
MA20:9.290.7%
MA50:9.816.4%
MA100:8.864.1%
MA200:7.7518.9%
STO9:64.10
STO14:58.82
RSI14:40.24
WPR14:-9.09 
MTM14:-0.04
ROC14:0.00 
ATR:0.31 
Week High:9.503.0%
Week Low:8.508.5%
Month High:10.6215.2%
Month Low:8.5018.9%
Year High:12.2532.9%
Year Low:3.62154.7%